InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Kaiser Peter. Officer active across 2 companies, notably Ocular Therapeutix, INC. Aggregated, 10 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €265k. History available since 2 October 2024. The latest transaction was filed on 24 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Kaiser Peter is Chief Development Officer at OCULAR THERAPEUTIX, INC and Ocular Therapeutix, INC. He has filed 9 transactions in total, and across the recent filings available between 2024-10-04 and 2026-02-25, the reported sell amount is EUR 236621, with the transaction nature listed as Cession.